<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<html>
  <head>
    <title>Depressão associada a demência - Slide 9</title>
  </head>

  <body>
    <h1>
      Uso de antidepressivos na depressão associada à demência:<br />
      Ensaios clínicos randomizados, duplo-cegos, controlados com placebo
    </h1>
  <div id="um">
    <table class="dTable" cellpadding="3" cellspacing="3">
      <thead>
        <th>Autores/ ano</th>
        <th>Instrumentos</th>
        <th>N</th>
        <th>Antidepressivo</th>
        <th>Duração (semanas)</th>
        <th>Resultado</th>
      </thead>
      <tbody>
        <tr>
          <td class="center" id="meme">Reifler et al./ 1989</td>
          <td class="center">DSM-III<br />HAM-D</td>
          <td class="center">28</td>
          <td class="center">Imipramina</td>
          <td class="center">8</td>
          <td>Imipramina = placebo</td>
        </tr>
        <tr>
          <td class="center">Nyth et al./ 1992</td>
          <td class="center">HAM-D<br />MADRS<br />CGI<br />GBS</td>
          <td class="center">23</td>
          <td class="center">Citalopram</td>
          <td class="center">6</td>
          <td>Tendência de melhora do humor pela GBS</td>
        </tr>
        <tr>
          <td class="center">Petracca et al./ 1996</td>
          <td class="center">HAM-D</td>
          <td class="center">21</td>
          <td class="center">Clorimipramina</td>
          <td class="center">6</td>
          <td>Clorimipramina > placebo</td>
        </tr>
        <tr>
          <td class="center">Magai et al./ 2000</td>
          <td class="center">CSDD<br />Gestalt</td>
          <td class="center">31</td>
          <td class="center">Sertralina</td>
          <td class="center">8</td>
          <td>Sertralina = placebo</td>
        </tr>
        <tr>
          <td class="center">Lyketsos et al./  2000</td>
          <td class="center">CSDD<br />HAM-D</td>
          <td class="center">22</td>
          <td class="center">Sertralina</td>
          <td class="center">12</td>
          <td>Sertralina > placebo (respondedores parciais)</td>
        </tr>
        <tr>
          <td class="center">Petracca et al./ 2001</td>
          <td class="center">DSM IV<br />HAM-D</td>
          <td class="center">41</td>
          <td class="center">Fluoxetina</td>
          <td class="center">6</td>
          <td>Fluoxetina = Placebo</td>
        </tr>
        <tr>
          <td class="center">Roth et al./ 1996</td>
          <td class="center">DSM III<br />HAM-D</td>
          <td class="center">511</td>
          <td class="center">Moclobemida</td>
          <td class="center">6</td>
          <td>Moclobemida > placebo</td>
        </tr>
        <tr>
          <td class="center">Lyketsos et al./ 2003</td>
          <td class="center">CSDD<br />HAM-D</td>
          <td class="center">44</td>
          <td class="center">Sertralina</td>
          <td class="center">12</td>
          <td>Sertralina > placebo</td>
        </tr>
        <tr>
          <td class="center">Cunha  et al./ 2007</td>
          <td class="center">DSM IV<br />CSDD<br />MMES<br />MADRS</td>
          <td class="center">31</td>
          <td class="center">Venlafaxina</td>
          <td class="center">6</td>
          <td>Venlafaxina =  placebo</td>
        </tr>
	  <tbody>
    </table>
  </div>
  </body>
</html>
